ID   TGBC14TKB
AC   CVCL_3340
SY   TGBC-14-TKB; TGBC-14
DR   CLO; CLO_0050016
DR   BioSample; SAMN03472174
DR   Cosmic; 2629293
DR   Cosmic; 2674057
DR   RCB; RCB1186
DR   Wikidata; Q54972235
RX   PubMed=21451941;
RX   PubMed=27231123;
CC   Population: Japanese.
CC   Characteristics: Established from a tumor passaged through a nude mice (RCB=RCB1186).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): RCB
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 14
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
RX   PubMed=21451941; DOI=10.1007/s00534-011-0376-7;
RA   Sato J., Kimura T., Saito T., Anazawa T., Kenjo A., Sato Y.,
RA   Tsuchiya T., Gotoh M.;
RT   "Gene expression analysis for predicting gemcitabine resistance in
RT   human cholangiocarcinoma.";
RL   J. Hepatobiliary Pancreat. Sci. 18:700-711(2011).
//
RX   PubMed=27231123; DOI=10.1158/2159-8290.CD-15-1442;
RA   Saha S.K., Gordan J.D., Kleinstiver B.P., Vu P., Najem M.S., Yeo J.-C.,
RA   Shi L., Kato Y., Levin R.S., Webber J.T., Damon L.J., Egan R.K.,
RA   Greninger P., McDermott U., Garnett M.J., Jenkins R.L.,
RA   Rieger-Christ K.M., Sullivan T.B., Hezel A.F., Liss A.S., Mizukami Y.,
RA   Goyal L., Ferrone C.R., Zhu A.X., Joung J.K., Shokat K.M., Benes C.H.,
RA   El-Bardeesy N.;
RT   "Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity
RT   and SRC dependence in intrahepatic cholangiocarcinoma.";
RL   Cancer Discov. 6:727-739(2016).
//